rct
    2010
    High Quality

    Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo-controlled study

    Jorgensen SP, Agnholt J, Glerup H

    Published in Alimentary Pharmacology & Therapeutics

    Methodology

    Randomized double-blind trial of 1200 IU vitamin D3 daily versus placebo in Crohn's disease in remission.

    Key Findings

    Relapse rate was 13% with vitamin D3 versus 29% with placebo (p=0.06).

    Conclusions

    Vitamin D3 may reduce relapse risk in Crohn's disease but did not reach significance.

    Limitations

    Underpowered; borderline p value.

    Supplements Studied

    Vitamin D
    Vitamin

    The relapse rate was 13% in the vitamin D3 group versus 29% in the placebo group (P = 0.06).

    Related Health Concerns

    Crohn's Disease

    Study Details

    Year:2010
    Sample Size:108
    Duration:52 weeks
    Quality Score:7/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.